[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368813-105":59,"doc-detail-368813-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","septin-9-gene-methylation-and-carcinoembryonic-antigen-as-key-biomarkers-in-colorectal-cancer-a-retrospective-study-on-prognosis-and-recurrence","Septin-9 gene methylation and carcinoembryonic antigen as key biomarkers in colorectal cancer - A retrospective study on prognosis and recurrence","","This retrospective study evaluates the clinical value of plasma Septin-9 gene methylation (mSEPT9) and carcinoembryonic antigen (CEA) for colorectal cancer (CRC) and analyzes their relationships with clinicopathological features and recurrence. Eighty-one CRC patients and 73 healthy controls were enrolled from January 2021 to January 2023. Plasma mSEPT9 (qPCR) and CEA (electrochemiluminescence) were measured, and patients were followed for 1 year. mSEPT9 and CEA positivity were independently associated with CRC risk and postoperative recurrence/metastasis, and combined testing improved diagnostic performance with AUC 0.829, sensitivity 78.00%, and specificity 90.00%.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/septin-9-gene-methylation-and-carcinoembryonic-antigen-as-key-biomarkers-in-colorectal-cancer-a-retrospective-study-on-prognosis-and-recurrence/368813/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/septin-9-gene-methylation-and-carcinoembryonic-antigen-as-key-biomarkers-in-colorectal-cancer-a-retrospective-study-on-prognosis-and-recurrence/368813.png","ImageObject",300,407,{"name":92,"@type":93},"Elsa","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What biomarkers does the study evaluate for colorectal cancer?","Question",{"text":112,"@type":113},"The study evaluates plasma Septin-9 gene methylation (mSEPT9) and carcinoembryonic antigen (CEA) as biomarkers in colorectal cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was mSEPT9 and CEA measured in the study?",{"text":117,"@type":113},"mSEPT9 was measured using quantitative PCR, and CEA was measured using electrochemiluminescence.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the study find about recurrence/metastasis after surgery?",{"text":121,"@type":113},"Postoperative persistent mSEPT9 positivity showed a stronger association with recurrence/metastasis than CEA, and combined detection achieved better overall diagnostic performance than either marker alone.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368813,1790471805,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},137455077381,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","®  \n Observational Study   \nSeptin-9 gene methylation and carcinoembryonic antigen as key biomarkers in colorectal cancer A retrospective study on prognosis and recurrence  \nJing Liu, MMa ,*  \n\n| Abstract\u003Cbr>This study investigates the clinical value of plasma Septin-9 gene methylation (mSEPT9) and carcinoembryonic antigen (CEA) in colorectal cancer (CRC), and their correlations with clinicopathological features and recurrence. A retrospective study included 81 CRC patients (observation group) and 73 healthy controls (comparison group) from January 2021 to January 2023, with pathological diagnosis as the gold standard. Plasma mSEPT9 (via quantitative PCR) and CEA (via electrochemiluminescence) levels were measured. Associations between mSEPT9 Ct values/CEA status and clinicopathological parameters (tumor location, metastasis, tumor diameter, etc) were analyzed. The observation group was followed for 1 year to assess the relationship between persistent positivity of mSEPT9/CEA before and after surgery and recurrence/metastasis. CEA positivity was significantly associated with tumor location (P \u003C .0001), distant metastasis (P \u003C .0001), and lymph node metastasis (P \u003C .0001) . mSEPT9 positivity correlated with distant metastasis (P = .009) and tumor diameter ≥ 5 cm (P = .001) . Compared with negative cases, mSEPT9-positive individuals had a 12.08-fold higher risk of CRC (OR = 12.079; 95% CI = 3.699–39.447, P \u003C .001), and CEApositive individuals had a 5 .30-fold higher risk (OR = 5.301; 95% CI = 1.339–20.981, P = .017) . Postoperative persistent mSEPT9 positivity showed a stronger association with recurrence/metastasis than CEA (χ² = 7.227, P = .007 vs χ² = 5.739, P = .017) . Combined detection of mSEPT9 and CEA achieved an area under the curve of 0 .829, with sensitivity of 78.00% and specificity of 90.00%, outperforming single-marker analysis. Both mSEPT9 and CEA positivity are independent risk factors for CRC. mSEPT9 is closely linked to tumor burden and distant metastasis, demonstrating higher sensitivity in monitoring postoperative recurrence. |\n| --- |\n| Abbreviations: AUC = area under the curve, CEA = carcinoembryonic antigen, CI = confidence interval , CRC = colorectal cancer, Ct = cycle threshold, mSEPT9 = Septin-9 gene methylation, OR = odds ratio, qPCR = quantitative polymerase chain reaction. |\n| Keywords: colorectal cancer, correlation, cycle threshold, mSEPT9, pathological features |\n\n1. Introduction  \nCRC arises through a complex, multistage process influenced by various factors, including dietary habits, lifestyle, and environmental exposures.[1] The disease’s pathogenesis involves both irreversible genetic mutations and reversible epigenetic alterations, with DNA methylation being a critical epigenetic mechanism driving its initiation and progression. [2]  \nStudies have demonstrated that plasma methylation testing of the Septin-9 gene exhibits high sensitivity and specificity for early adjunctive diagnosis of CRC, positioning it as a promising biomarker for detecting this malignancy.[3] Located on chromosome 17q25.3, the SEPT9 gene encodes the Septin-9 protein – a conserved member of the Septin family of GTPbinding proteins. This protein plays a critical role in essential physiological processes, including cytoskeletal remodeling,  \nThe authors have no funding and conflicts of interest to disclose.  \nThe datasets generated during and/or analyzed during the current study are not publicly available, but are available from the corresponding author on reasonable request.  \nThe content of this article is merely a sharing of academic research results, aiming to provide references for medical practice. It does not constitute any clinical diagnosis and treatment advice, medication guidance, or basis for health decision-making. The specific medical plan should be formulated by a professional physician based on the individual condition of the patient. Please do not adjust the treatment plan by yourself according to the conte","cbCaihkEmC3Eihl4","https://ap.wps.com/l/cbCaihkEmC3Eihl4","pdf",711561,"English","# Abstract\n# Abbreviations\n# Keywords\n# Introduction\n## Background and rationale\n## Biomarker focus: Septin-9 methylation","[{\"question\":\"What biomarkers does the study evaluate for colorectal cancer?\",\"answer\":\"The study evaluates plasma Septin-9 gene methylation (mSEPT9) and carcinoembryonic antigen (CEA) as biomarkers in colorectal cancer.\"},{\"question\":\"How was mSEPT9 and CEA measured in the study?\",\"answer\":\"mSEPT9 was measured using quantitative PCR, and CEA was measured using electrochemiluminescence.\"},{\"question\":\"What did the study find about recurrence/metastasis after surgery?\",\"answer\":\"Postoperative persistent mSEPT9 positivity showed a stronger association with recurrence/metastasis than CEA, and combined detection achieved better overall diagnostic performance than either marker alone.\"}]","Septin-9 gene methylation and carcinoembryonic antigen as key biomarkers in colorectal cancer - A retrospective study on prognosis and recurrence | PDF",1790178735,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9427075f1b85cd67cb17be0fb6c2a23d.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/190d2929bb7c5dd55029fba6fbb4479d.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b12d8432d75879b069ee971e87e0528c.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/888c85635974d214aac1dee1d6c0c63a.webp",980,1306]